glp-1 shortage canada news today What happens when demand outpaces supply? The transformed the market., Caleb Silver breaks down how the FDA's shortage designation opened the door to compounded GLP-1s, increased New study ties weight-loss drugs

In patients with CKD who are at increased risk for cardiovascular events, use of a GLP-1 RA may reduce the risk of progression of albuminuria, cardiovascular events, or both

January 19, 2025: Important Trial Date Set in Group Ozempic Lawsuit Many people who were harmed by Ozempic have joined the group lawsuit for GLP-1 drugs (MDL 3094: GLP-1 Products Liability Litigation)

Jody Dushay, an assistant professor of medicine at Harvard Medical School and an attending physician in endocrinology at Beth Israel Deaconess Medical Center, who prescribes weight-loss medications

After the lawsuit, the FDA had temporarily paused enforcement but reaffirmed its position in December

When paired with lifestyle modifications, drugs in this category have shown efficacy in managing both type 2 diabetes and promoting weight loss

Shortage Status Changes The FDA declared the semaglutide shortage resolved in February 2025